Anika Therapeutics (ANIK) Selling, General & Administrative (2010 - 2026)
Anika Therapeutics (ANIK) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 449.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 285.93 Mn | 247.52 Mn | 21.24 Mn | 10.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.95 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 12.08 Mn |
| Sep 30, 2025 | 11.87 Mn |
| Jun 30, 2025 | 12.23 Mn |
| Mar 31, 2025 | 12.91 Mn |
| Dec 31, 2024 | 11.32 Mn |
| Sep 30, 2024 | 13.54 Mn |
| Jun 30, 2024 | 15.62 Mn |
| Mar 31, 2024 | 15.07 Mn |
| Dec 31, 2023 | -15.59 Mn |
| Sep 30, 2023 | 24.83 Mn |
| Jun 30, 2023 | 23.69 Mn |
| Mar 31, 2023 | 27.00 Mn |
| Dec 31, 2022 | -10.52 Mn |
| Sep 30, 2022 | 21.28 Mn |
| Jun 30, 2022 | 21.27 Mn |
| Mar 31, 2022 | 19.20 Mn |
| Dec 31, 2021 | 20.43 Mn |
| Sep 30, 2021 | 17.50 Mn |